Consultant Haematologist
The Institute of Cancer Research; Royal Marsden Hospital
Sutton, England, United Kingdom
Dr Martin Kaiser is a Reader in Molecular Haematology at the Institute of Cancer Research (ICR) and Haematology Consultant at the Royal Marsden Hospital in London, with special interest in multiple myeloma and its precursor conditions. His research focuses on molecular and imaging biomarkers in myeloma, with a view to personalisation of care and development of gentler, more efficacious treatments for patients with multiple myeloma. He also has a specific interest in drug regulatory policy and health technology assessment (HTA). He is vice chair of the UK NCRI myeloma trials subgroup and is actively involved in advocacy work aiming to improve patient access to diagnostics and therapy.
Disclosure information not submitted.
How to characterize and manage the functional high risk Myeloma
Thursday, September 26, 2024
9:20 AM – 9:30 AM East Coast USA Time
Thursday, September 26, 2024
10:00 AM – 10:30 AM East Coast USA Time